Lipopolysaccharide Causes Acquired CFTR Dysfunction in Murine Nasal Airways

Editor-in-Chief Cecelia E. Schmalbach, MD, MSc, is joined by senior author Bradford A. Woodworth, MD, and Associate Editor Dana L. Crosby, MD, MPH, to discuss how lipopolysaccharide can be used to generate a model of acquired cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction in murine nasal airways as outlined in the paper "Lipopolysaccharide Causes Acquired CFTR Dysfunction in Murine Nasal Airways," which published in the May 2025 issue of Otolaryngology–Head and Neck Surgery . They talk about CFTR as a potential driving process in recalcitrant chronic rhinosinusitis. Click here to read the full article.

You can listen to Lipopolysaccharide Causes Acquired CFTR Dysfunction in Murine Nasal Airways online on Radio and Podcast. Open the player on this page to stream the available audio.

Lipopolysaccharide Causes Acquired CFTR Dysfunction in Murine Nasal Airways is an episode from SAGE Otolaryngology by Chris Harris.

This episode is 22:31 long.

This episode was published on May 21, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from SAGE Otolaryngology when more episodes are available from the podcast feed.